Is class I recommendation for aspirin use in CVD prevention too strong? - PACE-CME

Is class I recommendation for aspirin use in CVD prevention too strong

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Effects of a guideline-based approach on achieving LDL-c goals
Effects of a guideline-based approach on achieving LDL-c goals
ESC 2022
Effects of a guideline-based approach on achieving LDL-c goals
- Aaram Omar Khader, MD
Women in cardiology research
Women in cardiology research
ESC 2022
Women in cardiology research
- Biljana Parapid, MD, PhD
Unexpected findings when comparing DOAC with VKA in rheumatic AF
Unexpected findings when comparing DOAC with VKA in rheumatic AF
ESC 2022
Unexpected findings when comparing DOAC with VKA in rheumatic AF
- Prof. Ganesan Karthikeyan, MD
Increased coronary atherosclerotic plaque activity is associated with all-cause mortality
Increased coronary atherosclerotic plaque activity is associated with all-cause mortality
ESC 2022
Increased coronary atherosclerotic plaque activity is associated with all-cause mortality
- Prof. David Newby, PhD